Costco Wholesale Corporation (NASDAQ:COST) has launched a weight management program to help its members in their weight loss journey. The program will provide access to popular weight loss medications from pharmaceutical giants Eli Lilly and Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO).
What Happened: Costco’s new weight loss initiative, in partnership with Sesame, a healthcare marketplace, will offer members a three-month clinical consultation and other services for $179, reported Fox Business.
The program will allow clinicians to prescribe medications such as Novo Nordisk’s Ozempic and Wegovy, and Eli Lilly’s Mounjaro and Zepbound, which have gained popularity for their weight loss benefits.
Sesame CEO David Goldhill said, “We are witnessing important innovations in medically-supervised weight loss. Sesame's unique model allows us not only to make high-quality specialty care like weight loss much more accessible and affordable, but also to empower clinicians to create care plans that are specific to — and appropriate for — each individual patient.”
This expanded partnership follows an earlier collaboration between Costco and Sesame, which provided Costco members with discounted core healthcare services. The new ...